| 17th Aug 2022 7:00 am |
RNS |
FDA New Drug Application File Acceptance for MMB |
| 17th Aug 2022 7:00 am |
RNS |
Statement: Zantac (ranitidine) litigation update |
| 16th Aug 2022 7:06 am |
RNS |
GSK completes acquisition of Affinivax, Inc. |
| 12th Aug 2022 7:00 am |
RNS |
Statement: Zantac (ranitidine) litigation |
| 11th Aug 2022 11:51 am |
RNS |
Director/PDMR Shareholding |
| 10th Aug 2022 4:57 pm |
RNS |
Director/PDMR Shareholding |
| 1st Aug 2022 6:10 pm |
RNS |
Total Voting Rights |
| 1st Aug 2022 1:43 pm |
RNS |
Director/PDMR Shareholding |
| 29th Jul 2022 2:00 pm |
RNS |
Director/PDMR Shareholding |
| 29th Jul 2022 10:00 am |
RNS |
GSK Board change |
| 28th Jul 2022 1:01 pm |
RNS |
Director/PDMR Shareholding |
| 27th Jul 2022 7:00 am |
RNS |
2nd Quarter Results |
| 26th Jul 2022 5:35 pm |
RNS |
Holding(s) in Company |
| 22nd Jul 2022 4:45 pm |
RNS |
Holding(s) in Company |
| 22nd Jul 2022 4:17 pm |
RNS |
Board and Committee Changes |
| 19th Jul 2022 7:00 am |
RNS |
Completion of GSK Share Consolidation |
| 18th Jul 2022 6:00 pm |
RNS |
Holding(s) in Company |
| 18th Jul 2022 7:00 am |
RNS |
Haleon demerger completion and share consolidation |
| 12th Jul 2022 9:48 am |
RNS |
Director/PDMR Shareholding |
| 11th Jul 2022 5:30 pm |
RNS |
GSK |
| 8th Jul 2022 6:04 pm |
RNS |
Director/PDMR Shareholding |
| 8th Jul 2022 5:30 pm |
RNS |
Director/PDMR Shareholding |
| 8th Jul 2022 3:53 pm |
RNS |
Director/PDMR Shareholding |
| 8th Jul 2022 3:33 pm |
RNS |
Director/PDMR Shareholding |
| 8th Jul 2022 3:10 pm |
RNS |
Director/PDMR Shareholding |
| 6th Jul 2022 4:30 pm |
RNS |
Result of General Meeting |
| 6th Jul 2022 10:11 am |
RNS |
Director/PDMR Shareholding |
| 5th Jul 2022 12:43 pm |
RNS |
GSK disclose discontinued operations from Q2 2022 |
| 5th Jul 2022 9:45 am |
RNS |
Director/PDMR Shareholding |
| 5th Jul 2022 9:30 am |
RNS |
Director/PDMR Shareholding |
| 1st Jul 2022 3:27 pm |
RNS |
Total Voting Rights |
| 1st Jul 2022 2:45 pm |
RNS |
GSK completes acquisition of Sierra Oncology |
| 28th Jun 2022 5:56 pm |
RNS |
Director/PDMR Shareholding |
| 28th Jun 2022 7:00 am |
RNS |
GSK files Shingrix 18+ at risk indication in Japan |
| 27th Jun 2022 4:08 pm |
RNS |
Director/PDMR Shareholding |
| 24th Jun 2022 3:44 pm |
RNS |
Director/PDMR Shareholding |
| 16th Jun 2022 10:58 am |
RNS |
Director/PDMR Shareholding |
| 10th Jun 2022 7:00 am |
RNS |
Positive phase III data for GSK’s RSV OA vaccine |
| 9th Jun 2022 4:28 pm |
RNS |
Director/PDMR Shareholding |
| 7th Jun 2022 5:17 pm |
RNS |
Director/PDMR Shareholding |
